AMATI, GABRIELE
 Distribuzione geografica
Continente #
AS - Asia 1.376
NA - Nord America 937
EU - Europa 759
SA - Sud America 165
AF - Africa 36
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.282
Nazione #
US - Stati Uniti d'America 885
CN - Cina 457
SG - Singapore 418
IT - Italia 351
VN - Vietnam 137
HK - Hong Kong 128
BR - Brasile 119
GB - Regno Unito 79
KR - Corea 72
DE - Germania 55
SE - Svezia 48
FR - Francia 47
IN - India 47
RU - Federazione Russa 46
FI - Finlandia 43
CA - Canada 29
NL - Olanda 23
ID - Indonesia 22
AR - Argentina 17
BD - Bangladesh 17
MX - Messico 16
AT - Austria 15
CO - Colombia 11
JP - Giappone 11
PL - Polonia 10
TR - Turchia 10
ZA - Sudafrica 10
AU - Australia 8
MA - Marocco 8
PK - Pakistan 8
ES - Italia 7
KE - Kenya 6
IQ - Iraq 5
SA - Arabia Saudita 5
TW - Taiwan 5
UA - Ucraina 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
EC - Ecuador 4
NP - Nepal 4
AZ - Azerbaigian 3
BE - Belgio 3
GR - Grecia 3
JO - Giordania 3
LT - Lituania 3
PE - Perù 3
UZ - Uzbekistan 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
CL - Cile 2
EG - Egitto 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
IL - Israele 2
KG - Kirghizistan 2
NG - Nigeria 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
PY - Paraguay 2
SI - Slovenia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CH - Svizzera 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
IE - Irlanda 1
IR - Iran 1
JM - Giamaica 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
ME - Montenegro 1
MR - Mauritania 1
MV - Maldive 1
PH - Filippine 1
RE - Reunion 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TH - Thailandia 1
Totale 3.282
Città #
Singapore 265
Hefei 241
Santa Clara 185
Ashburn 146
San Jose 131
Hong Kong 127
Bologna 76
Seoul 70
London 46
Ho Chi Minh City 43
Los Angeles 41
Beijing 40
Hanoi 36
Modena 31
Munich 28
Parma 26
Lauterbourg 24
Ovada 24
Milan 23
New York 21
Helsinki 20
Hillsboro 20
Council Bluffs 18
Chicago 17
Reggio Emilia 17
São Paulo 17
Orem 15
Jakarta 14
Moscow 14
The Dalles 14
Trieste 14
Kent 13
Chennai 12
Florence 12
Lappeenranta 11
Turku 11
Montreal 10
Portsmouth 10
Tokyo 10
Buffalo 9
Amsterdam 8
Houston 8
Mexico City 8
Rome 8
Shanghai 8
Stockholm 8
Toronto 8
Turin 8
Warsaw 8
Atlanta 7
Da Nang 7
Dallas 7
Denver 7
Düsseldorf 7
Southend 7
Boardman 6
Brooklyn 6
Chandler 6
Johannesburg 6
Nuremberg 6
Porto Alegre 6
Salt Lake City 6
Baghdad 5
Boston 5
New Delhi 5
Ninh Bình 5
Nyköping 5
Ottawa 5
San Francisco 5
Thái Bình 5
Delhi 4
Dhaka 4
Falkenstein 4
Formigine 4
Guangzhou 4
Haiphong 4
Kyiv 4
Mumbai 4
Nairobi 4
Pune 4
Vienna 4
Yubileyny 4
Zhengzhou 4
Amman 3
Ankara 3
Baku 3
Bogotá 3
Brasília 3
Brusciano 3
Brussels 3
Camposanto 3
Cesena 3
City of London 3
Columbus 3
Courbevoie 3
Córdoba 3
Dammam 3
Heidelberg 3
Jinan 3
Karachi 3
Totale 2.201
Nome #
Assessing hand grasp in patients with systemic sclerosis using the 16-grasp test: Preliminary results from a multidisciplinary study group 222
NATURAL HISTORY OF CRYOGLOBULINEMIA FROM 2000 TO 2018 FROM THE LABORATORY POINT OF VIEW: AN ANALYSIS OF CRYOGLOBULIN CHARACTERISTICS IN A SINGLE CENTER. 211
The predictive role of the TAPSE/sPAP ratio for cardiovascular events and mortality in systemic sclerosis with pulmonary hypertension 200
Promising use of filgotinib in patients affected by systemic sclerosis: Preliminary data from a case series of 5 patients 187
ORAL MANIFESTATIONS IN SYSTEMICSCLEROSIS: CLINICAL EVALUATION OF APERSONAL CASE SERIES OF 13 SCLERODERMAPATIENTS 186
Analysis of cryoproteins with a focus on cryofibrinogen: a study on 103 patients 184
Evaluation of an interprofessional education intervention in partnership with patient educators 181
Altered pathways of keratinization, extracellular matrix generation, angiogenesis, and stromal stem cells proliferation in patients with systemic sclerosis 178
EFFICACY OF CERTOLIZUMAB PEGOL FOR DISEASE CONTROL OF PATIENTS AFFECTED BY ENTEROPATHIC SPONDYLARTHRITIS FOLLOWED BY THE JOINT GASTRO-RHEUMATOLOGICAL CLINIC 175
Cryofibrinogen: A possibile risk factor in systemic sclerosis 171
Cryoproteinemia: new frontiers for clinicians and the laboratory 165
THE PREDICTIVE ROLE OF THE TAPSE/sPAP RATIO FOR CARDIOVASCULAR EVENTS AND MORTALITY IN SYSTEMIC SCLEROSIS COMPLICATED BY PULMONARY HYPERTENSION 163
PROBABILITÀ DI SIEROCONVERSIONE DEL TEST QUANTIFERON DURANTE LA TERAPIA BIOTECNOLOGICA: DATI PRELIMINARI DI UNO STUDIO RETROSPETTIVO CONDOTTO PRESSO L’ARTHRITIS CLINIC DELL’AZIENDA OSPEDALIERO-UNIVERSITARIA POLICLINICO DI MODENA 156
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 156
A New Promising Role for Selexipag in the Treatment of Scleroderma Vasculopathy: Preliminary Results From a Third Level Italian Scleroderma Center 141
SAFETY AND EFFICACY OF INTRAVENOUS ILOPROST IN THE TREATMENT AND PREVENTION OF SCLERODERMA-RELATED DIGITAL ULCERS 140
Role of COVID-19 in the progression of scleroderma interstitial lung disease and new onset pulmonary hypertension: a challenging case report. 127
Secondary cryofbrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study 126
Secondary cryofibrinogenemia is related to more severe microangiopathic involvement in systemic sclerosis: results from a retrospective observational study. 117
Prevalence of sacroiliitis on magnetic resonance enterography in Crohn's disease and its association with intestinal findings: a monocentric observational cross-sectional study 75
Role of musculoskeletal ultrasound in diagnosing and managing chronic inflammatory arthritis in ov erweight and obese patients: a narrative review 27
Does Prior Exposure Affect Retention? A Real‑World, Multicentre Assessment of IL‑17 Inhibitor Cycling in Psoriatic Arthritis 23
Totale 3.311
Categoria #
all - tutte 10.759
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.759


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 2 1 2
2021/202225 0 3 1 2 1 0 0 3 2 1 7 5
2022/202327 2 3 1 1 2 3 2 2 6 3 0 2
2023/2024131 4 0 9 14 19 2 9 1 2 2 27 42
2024/20251.170 29 20 35 73 171 117 109 90 140 73 134 179
2025/20261.940 193 133 213 301 276 108 260 87 195 174 0 0
Totale 3.311